Form D · Biotechnology
BioTraceIT Corp
Philadelphia, PA · CIK 0001642043
Offering snapshot reported May 22, 2015 · SEC filing
- Reported sold
- Yet to sell Offering amount: $3.5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $60K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 22, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-240449
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None. | None |
Source: Form D, filed May 22, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Deborah Dullen | Director, Executive |
| Leonard J Shore | Director, Executive |
| Jeffrey R Shore | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1518 Walnut St Suite 1002
Philadelphia, PA, 19102
Philadelphia, PA, 19102